During the past decade, "Theagenion" Anticancer Hospital of Thessaloniki, 2nd Dep of Medical Oncology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in ""Theagenion" Anticancer Hospital of Thessaloniki, 2nd Dep of Medical Oncology" #1 sponsor was "Hellenic Oncology Research Group" with 26 trials, followed by "Celcuity, Inc." with 1 trials sponsored, "Meletios A. Dimopoulos" with 1 trials sponsored, "University Hospital of Crete" with 1 trials sponsored and "Yuhan Corporation" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in ""Theagenion" Anticancer Hospital of Thessaloniki, 2nd Dep of Medical Oncology" #1 collaborator was "University Hospital of Crete" with 16 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in ""Theagenion" Anticancer Hospital of Thessaloniki, 2nd Dep of Medical Oncology" are "Breast Cancer" (12 trials), "Non Small Cell Lung Cancer" (4 trials), "Ovarian Cancer" (4 trials), "Colorectal Cancer" (3 trials) and "Metastatic Colorectal Cancer" (2 trials). Many other conditions were trialed in ""Theagenion" Anticancer Hospital of Thessaloniki, 2nd Dep of Medical Oncology" in a lesser frequency.

Most popular intervention types in ""Theagenion" Anticancer Hospital of Thessaloniki, 2nd Dep of Medical Oncology" are "Drug" (26 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (8 trials), "Epirubicin" (7 trials), "Bevacizumab" (6 trials), "Capecitabine" (4 trials) and "Carboplatin" (4 trials). Other intervention names were less common.

The vast majority of trials in ""Theagenion" Anticancer Hospital of Thessaloniki, 2nd Dep of Medical Oncology" are 17 trials for "All" genders and 13 trials for "Female" genders.

Currently, there are NaN active trials in ""Theagenion" Anticancer Hospital of Thessaloniki, 2nd Dep of Medical Oncology". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in "Theagenion" Anticancer Hospital of Thessaloniki, 2nd Dep of Medical Oncology, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in "Theagenion" Anticancer Hospital of Thessaloniki, 2nd Dep of Medical Oncology, 4 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".